Inventiva S.A IVA 深 滬
等待開盤 09-03 09:30:00 美东时间
5.26
-0.930
-15.02%
華盛通- 最 高5.5284
- 今 開5.49
- 成交量 17.96万股
- 最 低 5.21
- 昨 收 6.19
- 總市值 7.31亿
- 52周最高 6.4999
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 1.53
- 委 比 -98.68%
- 總股本 1.39亿
- 歷史最高 19.064
- 量 比 1.48
- 振 幅 5.14%
- 歷史最低 1.53
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Guggenheim Maintains Buy on Inventiva, Raises Price Target to $13
Guggenheim analyst Etzer Darout maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $9 to $13.
09-02 19:44
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in th...
08-28 22:44
MASH drug developers rise as FDA accepts lenient trial requirement
Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an easy-to-m...
08-28 01:44
Inventiva surges as Piper Sandler issues bullish view citing lead asset
Inventiva (NASDAQ:IVA) climbed ~15% on Wednesday after Piper Sandler launched its coverage with an Overweight recommendation, citing the French biotech’s lead candidate, lanifibranor, targeted at the ...
08-27 23:52
Kohl's Posts Better-Than-Expected Earnings, Joins MongoDB, Canada Goose, Donaldson Company And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on ...
08-27 22:57
科技大佬，大发AI战争财
VR教父，变身AI军火商 因为参与AI军火生意，32岁的帕尔默·拉奇正在经历一场财富爆炸。从去年到今年，其个人资产至少翻了一倍，已超过20亿美元。 和多数少年成...
08-27 10:04
What's Going On With ImmunityBio Shares Tuesday?
ImmunityBio shares are trading higher Tuesday after the company announced its chemotherapy-free combination showed 100% disease control results and is planning a Phase 2 trial.
08-27 00:33
ImmunityBio's Chemotherapy-Free Combo Shows 100% Disease Control In Early Glioblastoma Trial, Plans Phase 2
First chemotherapy-free trial combining ANKTIVA, an IL-15 agonist, natural killer (NK) cell therapy, and Optune immune-stimulating device for patients with glioblastoma (GBM) brain tumors who have failed
08-26 20:34
2025净水器十大品牌推荐
在现代生活中，水质安全已成为人们关注的焦点。水中可能含有的杂质、微塑料、重金属、细菌等有害物质，不仅影响饮水口感，更会对健康造成潜在威胁。因此，选择一款优质...
08-15 13:56
ImmunityBio's ANKTIVA Now Available At Houston VA, Offering New Bladder Cancer Treatment For Veterans
ImmunityBio, Inc. ((IBRX), a leading immunotherapy company, today announced the Michael E. DeBakey Department of Veterans Affairs (VA) Medical Center in Houston recently became the first VA hospital in the Houston region
08-11 20:33
